Caspase 3 inactivation to suppress Fas-mediated apoptosis: Identification of binding domain with p21 and ILP and inactivation machinery by p21

Oncogene

Volumn 18, Issue 5, 1999, Pages 1239-1244

  Suzuki, Atsushi ^a   Tsutomi, Yumi ^a   Miura, Masayuki ^b   Akahane, Kouichi ^a  

^a DAIICHI SANKYO CO   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Caspase 3; Fas; ILP; p21; Serineproteinase

Indexed keywords

CASPASE 3; FAS ANTIGEN; PROTEIN P21; SERINE PROTEINASE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; COMPLEX FORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; BINDING SITES; CASPASE 3; CASPASES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME PRECURSORS; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BINDING; TUMOR CELLS, CULTURED;

EID: 0033521925     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202409     Document Type: Article

References (23)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornbery NA, Wong WW and Yuan J. (1996). Cell, 87, 171.
2. Boldin MP, Goncharov TM, Golstev YV and Wallach D. (1996). Cell, 85, 803-815.
3. Chen J, Jackson PK, Kirschner MW and Dutta A. (1995). Nature, 374, 386-388.
4. Deveraux QL, Takahashi R, Salvesen GS and Reed JC. (1997). Nature, 388, 300-304.
5. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G and Alnemri ES. (1996). Proc. Natl. Acad. Sci. USA, 93, 7464-7469.
6. Fernandes-Alnemri T, Litwack G and Alnemri ES. (1994). J. Biol. Chem., 267, 30761-30764.
7. Hasegawa J, Kamada S, Kamiike W, Shimizu S, Imazu T, Matsuda H and Tsujimoto Y. (1996). Cancer Res., 56, 1713-1718.
8. Li Y, Jenkins CW, Nichols MA and Xiong Y. (1994). Oncogene, 9, 2261-2268.
9. Luo Y, Hurwitz J and Massague J. (1995). Nature, 375, 159-161.
10. Miyazaki K, Umenishi F, Funahashi K, Koshikawa N, Yasumitsu H and Umeda M. (1992). Biochem. Biophys. Res. Commun., 185, 852-859.
11. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. (1996). Cell, 85, 817-827.
12. Nagata S and Golstein P. (1995). Science, 267, 1449-1456.
13. Nagata S. (1997). Cell, 88, 355-365.
14. Nakanishi M, Robetorye RS, Adami GR, Pereira-Smith OM and Smith JR. (1995). EMBO J., 14, 555-563.
15. Nicholson DW, Ali A, Thornbery NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnic YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK. (1995). Nature, 376, 37-43.
16. Suzuki A, Iwasaki M, Kato M and Wagai N. (1997a). Exp. Cell. Res. 233, 41-47.
17. Suzuki A, Iwasaki M and Wagai N. (1997b). Exp. Cell. Res., 233, 48-55.
18. Suzuki A, Tsutomi Y, Akahane K, Araki T and Miura M. (1998). Oncogene, in press.
19. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM. (1995). Cell, 81, 801-809.
20. Williams MS and Henkart PA. (1994). J. Immunol., 153, 4247-4255.
21. Wyllie AH, Kerr JFR and Currie AR. (1980). Int. Rev. Cytol., 68, 251-306.
22. Xiong Y, Zhang H and Beach D. (1993). Genes Dev., 7, 1572-1583.
23. Yonehara, S, Ishii A and Yonehara M. (1989). J. Exp. Med., 169, 1747-1756.